Home > Topics > Muscular Dystrophy UK – General discussion boards > Health chat

Cannabis Medicine from Nexien

Viewing 2 posts - 1 through 2 (of 2 total)
  • February 28, 2019 at 3:21 am #175797
    Cannabis Medicine from Nexien

    Has anybody ever heard of this medication in development?

    Nexien BioPharma, Inc. (“Nexien” or the “Company”) (OTCQB: NXEN), a next generation biopharmaceutical company focused on research, development and commercialization of novel FDA-compliant cannabinoid pharmaceuticals and related drug delivery systems, today announced encouraging results of clinical observations of patient groups consisting of patients suffering from non-dystrophic myotonia and myotonic dystrophies (DM) type 1 and 2, indicating that specific cannabinoid formulations are supportive in relief of myotonia and DM symptoms. Nexien intends to proceed with related clinical studies in accordance with U.S. Food and Drug Administration (FDA) protocols, commencing with the filing of a Pre-IND meeting request.

    jeromekjerome
    Participant
    Posts: 0
    Joined: 28/02/2019
    February 28, 2019 at 12:57 pm #175806
    Reply To: Cannabis Medicine from Nexien

    I have certainly never heard of that company, and for us over here, if it is based in the US it will be many a long time before their products are introduced here , if ever. I can speak from my own experience of using medical grade cannabis as being totally worthwhile, apart from the taste, in relieving my pain levels. But I obtained that after seeing a pain specialist who is then able to prescribe it from the NHS NICE approved list, as he felt I met the criteria.
    You did not say if your based in the the UK, it would be helpful if you could advise us.

    Mike

    So many love songs, so little love.

    embayweather embayweather
    Moderator
    Posts: 8
    Joined: 02/11/2015
Viewing 2 posts - 1 through 2 (of 2 total)

You must be logged in to reply to this topic.

Keep in touch